Extreme Movers: GPT-6's picks for 2026-10-28
GPT-6 picked XYL, HRI, SOFI, KNSA, INOD for a 1-day horizon. Average directional return: +3.39%. Directions called correctly: 80%.
| Experiment | Extreme Movers |
|---|---|
| Model | GPT-6 |
| Prompt version | extreme-movers-v11 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-28 |
| Measured to | 2026-10-29 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | +3.39% |
| Directions called correctly | 80% |
| Benchmark return | -0.29% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | XYL | down | +1.59% | -1.59% | 69% | -1.30% | No |
| 2 | HRI | up | +3.43% | +3.43% | 67% | +3.73% | Yes |
| 3 | SOFI | up | +2.70% | +2.70% | 65% | +3.00% | Yes |
| 4 | KNSA | up | +8.33% | +8.33% | 58% | +8.63% | Yes |
| 5 | INOD | up | +4.08% | +4.08% | 53% | +4.37% | Yes |
The model's market view
Moderately constructive US equity sentiment supports selective continuation after positive earnings surprises, while company-specific guidance reductions create persistent downside pressure. The source session is October 27, 2026. Five liquid common stocks were selected from the session's largest gainers and losers. The strongest positive catalysts are improved earnings and guidance at Herc Holdings, SoFi Technologies, and Kiniksa Pharmaceuticals. Xylem faces a substantive negative earnings revision, while Innodata's unusually large decline reflects potentially serious but incompletely verified customer-contract concerns. The predictions favor continuation in four cases and a speculative reversal in one. All five stocks exceeded the $5 source-close price floor, $1 billion market-capitalization floor, and $20 million 20-day average dollar-volume floor. Dollar-volume figures were calculated using the 20 completed trading sessions from September 30 through October 27, 2026, as the arithmetic mean of each day's closing price multiplied by reported share volume, with fractional dollars truncated. This is a close-price-based dollar-volume proxy rather than exact exchange-reported trading turnover. Market capitalizations are October 27 closing-date figures, rounded only to the precision published by the data source. Reference prices are October 28 intraday observations, not October 27 closing prices. The future evaluation window is October 28, 2026 at 14:16:29.855 UTC through October 29, 2026 at 14:16:00 UTC. The primary score is the arithmetic mean of five direction-signed price returns, with direction accuracy evaluated separately. Neither realized score nor realized direction accuracy is available at prediction time. Important risks include broader market reversal, stretched post-earnings valuations, short covering, and news-driven volatility.
Why each pick
XYL
Rank 1 because Xylem has the clearest negative fundamental catalyst among the screened large-cap decliners. Shares fell 14.21% during October 27 after third-quarter revenue of approximately $2.20 billion missed expectations and management reduced full-year revenue guidance to approximately $8.95 billion. Adjusted EPS guidance was reduced from $5.55-$5.70 to $5.40-$5.45. The weakness reflects delayed customer projects and cautious spending, making the catalyst substantive rather than speculative. Continued analyst estimate reductions and institutional selling could extend the decline. October 28 intraday trading was already approximately 5.2% below the previous close at the latest accessible quote. The bearish thesis is continuation of the October 27 decline, not an opening-gap prediction. Risks include an oversold rebound, 10% organic order growth, a stronger backlog, and positive interpretations of planned divestitures. The reference price is an intraday Google Finance observation at 10:01:07 EDT, approximately 17 minutes before the 10:18 EDT research snapshot, rather than the prior session's $92.86 regular close. Source-session capitalization exceeded $21 billion. The 20-day dollar-volume figure is calculated from historical daily closing prices and volumes. Catalyst source: Xylem's official October 27 third-quarter earnings announcement.
HRI
Rank 2 because Herc Holdings delivered one of the strongest positive earnings reactions among liquid October 27 gainers. The stock gained 22.76% after reporting record third-quarter equipment rental revenue of $1.254 billion, an increase of 12%, adjusted EBITDA of $603 million, and higher full-year guidance. Improved fleet utilization, equipment pricing, operating leverage, and infrastructure-related rental demand support a substantive fundamental catalyst. The earnings release reports adjusted EBITDA margin expansion of 190 basis points. The stock continued advancing during October 28 morning trading, supporting a short-term continuation hypothesis. The principal risk is profit taking following a two-day advance exceeding 25%, with additional exposure to construction demand, financing costs, and cyclical economic conditions. The reference price of $164.77 is an intraday Stock Analysis quote timestamped 10:14 EDT on October 28, approximately four minutes before the research snapshot. The October 27 regular close was $156.06. Source-session market capitalization was approximately $5.22 billion. The reported 20-day dollar-volume measure is computed from closing prices multiplied by daily share volume. Catalyst source: Herc Holdings' official October 27 third-quarter earnings release published through Nasdaq.
SOFI
Rank 3 because SoFi combines a major positive earnings surprise with exceptional liquidity and renewed buying momentum. Shares gained 13.42% on October 27 after the company reported record quarterly adjusted net revenue of approximately $1.4 billion, representing 44% annual growth, and adjusted EBITDA of $470 million, representing 70% annual growth. Management increased full-year 2026 guidance to $5.04 billion in adjusted revenue and $1.66 billion in adjusted EBITDA, while introducing a 2027 revenue outlook of $6.4 billion. Member growth of 35% reinforces the substantive business-growth catalyst. October 28 morning trading showed further appreciation, supporting continuation. Risks include stretched short-term positioning, credit losses, consumer lending sensitivity to economic conditions, and profit taking after the earnings reaction. The latest accessible reference price is an intraday Stock Analysis observation of $16.99 at 10:14 EDT on October 28, roughly four minutes before the research snapshot; the October 27 regular close was $16.40. The source-close capitalization was $21.26 billion. Twenty-day dollar volume is calculated from daily historical closing prices and trading volumes. Catalyst source: SoFi Technologies' official October 27 earnings release.
KNSA
Rank 4 because Kiniksa Pharmaceuticals was among the October 27 session's strongest qualifying gainers, advancing 22.23% following a substantive commercial performance improvement. ARCALYST third-quarter net product revenue reached $286 million, approximately 58% above the prior year. Management raised 2026 expected ARCALYST revenue to $1.045-$1.050 billion from its previous $980-$995 million range. Strong prescription adoption and higher revenue guidance support a potential continuation of institutional buying. However, the unusually large prior-session increase creates meaningful profit-taking risk, while product concentration and clinical development uncertainty constrain confidence. October 28 morning trading was slightly negative, indicating less immediate continuation momentum than HRI or SOFI. The reference price of $88.62 is an intraday Stock Analysis observation timestamped 10:17 EDT on October 28, approximately one minute before the research snapshot, compared with the October 27 regular close of $89.20. October 27 capitalization was approximately $6.96 billion. The 20-day average dollar volume was calculated from actual reported historical closes and daily share volumes. Catalyst source: Kiniksa Pharmaceuticals' official October 27 quarterly financial results announcement.
INOD
Rank 5 because Innodata's 25.32% October 27 collapse creates a potentially attractive but unusually uncertain reversal setup. News reports described abrupt layoffs affecting approximately 550 workers in India and additional operations in the Philippines, with employee accounts suggesting that a major business assignment had been reduced. The reported workforce action is potentially substantive, but the identity of the affected customer, magnitude of contract losses, and future revenue impact were not independently confirmed through a company statement or SEC filing in the reviewed sources. Consequently, the market may have priced in a worse outcome than the evidence establishes. A stabilization or short-covering rebound is plausible after the exceptionally large decline. The counterargument is serious: confirmation of a material customer contraction could cause further sharp losses, especially given Innodata's exposure to concentrated AI data-services contracts. This is explicitly a reversal prediction because October 27 previous_change_percent was negative and the forecast direction is positive. The latest accessible reference price was $44.22 in an October 28 intraday Stock Analysis quote timestamped 10:03 EDT, about 15 minutes before the research snapshot, compared with the October 27 regular close of $44.74. Source-close capitalization was approximately $1.54 billion and the 20-day dollar-volume proxy exceeded $88 million. Catalyst sources: October 27 reporting by The Motley Fool and employee-account reporting summarized in subsequent coverage; the potential customer loss remains unconfirmed.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| Perplexity | VRT, WEN, ENPH, FFIV, AXGN | +2.90% | 80% |
| Muse Spark 1.1 | VRT, SOFI, AXGN, BA, FFIV | -1.30% | 40% |
| Grok 4.7 | HRI, KNSA, INOD, XYL, BA | +0.71% | 40% |
| GPT-5.1 | HRI, BA, XYL, KNSA, SOFI | +2.07% | 60% |
| DeepSeek | HRI, BA, XYL, KNSA, SOFI | +2.07% | 60% |
| Claude Sonnet 5.5 | UCTT, ENPH, INTA, INOD, RAPP | -0.22% | 60% |
| Gemini 3.6 Flash High | VRT, ENPH, WEN, UCTT, BSX | +1.50% | 100% |
Written up on ForecastNest Insights: Extreme Movers: GPT-6's picks for 2026-10-28.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.